Companies Home Search Profile

Technical Project Management for Generic Drug Development

Focused View

Aydan Ozden

5:37:05

16 View
  • 1 - 1-Introduct-on.pdf
  • 1 - Introduction.mp4
    09:04
  • 2 - 2-1-PM.pdf
  • 2 - Active Pharmaceutical Ingredient API Finished Pharmaceutical Product FPP.mp4
    06:14
  • 3 - 2-2-PM.pdf
  • 3 - Reference Listed Drug RLD Generic Multisource Pharmaceutical Products.mp4
    15:45
  • 4 - 2-3-PM.pdf
  • 4 - Pharmaceutical Bioequivalency Therapeutic Equivalency.mp4
    05:06
  • 5 - 2-4-PM.pdf
  • 5 - Reference Listed Drug RLD Development.mp4
    09:17
  • 6 - 2-5-PM.pdf
  • 6 - Generic Drug Development.mp4
    03:44
  • 7 - 2-6-PM.pdf
  • 7 - Comparision of Reference Listed Drug RLD Development Generic Drug Developmen.mp4
    12:01
  • 8 - 2-7-PM.pdf
  • 8 - Invitro Invivo Studies for Drug Product.mp4
    05:50
  • 9 - 3-1-PM.pdf
  • 9 - Project Elements of Project Cost Time Scope.mp4
    06:12
  • 10 - 3-2-PM.pdf
  • 10 - Priorizitation of Project Pipeline.mp4
    03:35
  • 11 - 3-3-PM.pdf
  • 11 - Project Phases.mp4
    11:30
  • 12 - 3-4-PM.pdf
  • 12 - Project Manager.mp4
    02:01
  • 13 - Project Team Project Stakeholders.mp4
    05:19
  • 14 - 3-6-PM.pdf
  • 14 - Project Management Tools.mp4
    05:09
  • 15 - 4-1-PM.xlsx
  • 15 - Project Diary for Generic Drug Development.mp4
    03:05
  • 16 - 4-2-PM.xlsx
  • 16 - Project Milestones for Generic Drug Development.mp4
    02:28
  • 17 - 4-3-PM.xlsx
  • 17 - Project Gantt Chart for Generic Drug Development.mp4
    04:07
  • 18 - 4-4-PM.xlsx
  • 18 - Generic Drug Development Project Phases.mp4
    02:24
  • 19 - 5-1-PM-DeskResearch.pdf
  • 19 - Desk Research for Generic Drug Development.mp4
    05:04
  • 20 - 5-2-PM-DeskResearch.pdf
  • 20 - European Medicines Agency EMA.mp4
    22:13
  • 21 - 5-3-1.pdf
  • 21 - 5-3-2.pdf
  • 21 - 5-3-PM-DeskResearch.pdf
  • 21 - World Health Organization WHO Food and Drug Administration FDA.mp4
    16:48
  • 22 - 5-4-PM-DeskResearch.pdf
  • 22 - Pharmacopoeias Dailymed.mp4
    08:34
  • 23 - 5-5-PM-DeskResearch.pdf
  • 23 - Drugscom.mp4
    02:45
  • 24 - 5-6-PM-DeskResearch.pdf
  • 24 - DrugBank.mp4
    06:59
  • 25 - 5-7-1.pdf
  • 25 - 5-7-PM-DeskResearch.pdf
  • 25 - Google Patents.mp4
    10:18
  • 26 - 5-8-PM-DeskResearch.pdf
  • 26 - Espacenet.mp4
    06:07
  • 27 - 6-1-PM-RawMaterialSelection.pdf
  • 27 - Raw Material Selection for Generic Drug Development.mp4
    02:27
  • 28 - 6-2-PM-RawMaterialSelection.pdf
  • 28 - Evaluation of Characteristics of API.mp4
    07:28
  • 29 - 6-3-PM-RawMaterialSelection.pdf
  • 29 - Stability Characteristics of API.mp4
    04:05
  • 30 - 6-4-PM-RawMaterialSelection.pdf
  • 30 - Evaluation of Suppliers of API.mp4
    05:27
  • 31 - 6-5-PM-RawMaterialSelection.pdf
  • 31 - Evaluation of Inactive Ingredient and Packaging Material.mp4
    06:04
  • 32 - 7-1-PM-PreFormulationStudies.pdf
  • 32 - PreFormulation Studies for Generic Drug Development.mp4
    02:11
  • 33 - 7-2-PM-PreFormulationStudies.pdf
  • 33 - Characterization of RLD.mp4
    01:22
  • 34 - 7-3-PM-PreFormulationStudies.pdf
  • 34 - Defining Quality Target Product Profile QTPP.mp4
    02:28
  • 35 - 74.mp4
    02:13
  • 35 - Evaluation of BE Requirements.mp4
    02:13
  • 36 - 7-5-PM-PreFormulationStudies.pdf
  • 36 - Evaluation of Inactive Ingredient Required for Formula.mp4
    02:45
  • 37 - 7-6-PM-PreFormulationStudies.pdf
  • 37 - Compatibility Study.mp4
    05:21
  • 38 - 7-7-PM-PreFormulationStudies.pdf
  • 38 - Supplying New material Apparatus Equipment.mp4
    01:22
  • 39 - 7-8-PM-PreFormulationStudies.pdf
  • 39 - Performing PreFormulation Trials.mp4
    03:14
  • 40 - 8-1-PM-AMD-Studies.pdf
  • 40 - Analytical Method Development Studies for Generic Drug Development 1.mp4
    03:48
  • 41 - 8-2-PM-AMD-Studies.pdf
  • 41 - Analytical Method Development Studies for Generic Drug Development 2.mp4
    01:01
  • 42 - 8-3-PM-AMD-Studies.pdf
  • 42 - Literature Search for Analytical Method Development.mp4
    04:05
  • 43 - 8-4-PM-AMD-Studies.pdf
  • 43 - Supplying Chemicals Materials Equipments.mp4
    02:02
  • 44 - 8-5-PM-AMD-Studies.pdf
  • 44 - Performing Method Development Studies.mp4
    01:19
  • 45 - 8-6-PM-AMD-Studies.pdf
  • 45 - Determining Acceptance Criteria.mp4
    03:42
  • 46 - 8-7-PM-AMD-Studies.pdf
  • 46 - Determining Dissolution Parameters.mp4
    02:09
  • 47 - 8-8-PM-AMD-Studies.pdf
  • 47 - Performing Stress Studies.mp4
    02:36
  • 48 - 8-9-PM-AMD-Studies.pdf
  • 48 - Performing PreValidation Studies.mp4
    01:26
  • 49 - 9-1-PM-FormulationforGDD.pdf
  • 49 - Formulation Studies for Generic Drug Development.mp4
    02:17
  • 50 - 9-2-PM-FormulationforGDD.pdf
  • 50 - Performing Formulation Trials.mp4
    04:06
  • 51 - 9-3-PM-FormulationforGDD.pdf
  • 51 - Optimizing Formulation by using QBD.mp4
    06:03
  • 52 - 9-4-PM-FormulationforGDD.pdf
  • 52 - Supplying Chemicals RawMaterials Equipments for Pilot Manufacturing.mp4
    01:30
  • 53 - 9-5-PM-FormulationforGDD.pdf
  • 53 - Preparing Formulations for Critical Material Attributes CMA.mp4
    07:11
  • 54 - 9-6-PM-FormulationforGDD.pdf
  • 54 - Preparing Formulations for Critical Quality Attribute CQA.mp4
    03:21
  • 55 - 9-7-PM-FormulationforGDD.pdf
  • 55 - Preparing Formulations for Critical Process Parameter CPP.mp4
    02:13
  • 56 - 9-8-PM-FormulationforGDD.pdf
  • 56 - Discriminitive Dissolution Parameters.mp4
    05:53
  • 57 - 9-9-PM-FormulationforGDD.pdf
  • 57 - Compatibility Study with Final Formula Components.mp4
    03:54
  • 58 - 10-1-PM-AnalyticalStudies.pdf
  • 58 - Analytical Studies for Generic Drug Development.mp4
    06:28
  • 59 - Pilot Manufacturing for Generic Drug Development.mp4
    08:00
  • 60 - 12-1-PM-AnalysisofPilotBatches.pdf
  • 60 - Analysis of Pilot Batches for Generic Drug Development.mp4
    04:31
  • 61 - 13-1-PM-BioequivalencyStudy.pdf
  • 61 - Performing Bioequivalency Study for Generic Drug Development.mp4
    07:33
  • 62 - 14-1-PM-RegistrationDossier.pdf
  • 62 - Preparation Registration Dossier for Generic Drug Development.mp4
    04:04
  • 63 - CONCLUSION-AYDANOZDEN.pdf
  • 63 - Conclusion.mp4
    07:34
  • Description


    Become a Technical Project Manager by Learning Generic Drug Development!

    What You'll Learn?


    • Understand Project Management
    • Learn Generic Drug Development
    • Understand Desk Research for Generic Drug Development
    • Learn Raw Material Selection for Generic Drug Development
    • Learn Pre-Formulation Studies for Generic Drug Development
    • Understand Analytical Method Development Studies for Generic Drug Development
    • Discuss Formulation Studies for Generic Drug Development
    • Learn Pilot Manufacturing for Generic Drug Development
    • Understand Bioequivalency Study for Generic Drug Development
    • Learn Registration Dossier for Generic Drug Development

    Who is this for?


  • Learners who desire to take a part in Pharmaceutical Industry
  • Existing pharma professionals who are looking to progress in their jobs
  • Anyone who is looking to get entry in pharmaceutical industry
  • What You Need to Know?


  • Require mobile/tablet/laptop/personal computer with internet
  • To be student, graduate and/or professional in related disciplines
  • More details


    Description

    COURSE CONTENT

    1 Introduction

    2 Introduction to Generic Drug Development

    2.1. Active Pharmaceutical Ingredient (API) & Finished Pharmaceutical Product (FPP)

    2.2. Reference Listed Drug (RLD) & Generic (Multisource) Pharmaceutical Products

    2.3. Pharmaceutical Bioequivalency (Therapeutic Equivalency)

    2.4. Reference Listed Drug (RLD) Development

    2.5. Generic Drug Development

    2.6. Comparision of Reference Listed Drug (RLD) Development & Generic Drug Development

    2.7. In-vitro & In-vivo Studies for Drug Product

    3 Introduction to Project Management

    3.1. Project & Elements of Project (Cost, Time, Scope)

    3.2. Priorizitation of Project (Pipeline)

    3.3. Project Phases

    3.4. Project Manager

    3.5. Project Team & Project Stakeholders

    3.6. Project Management Tools

    4 Project Management for Generic Drug Development

    4.1. Project Diary for Generic Drug Development

    4.2. Project Milestones for Generic Drug Development

    4.3. Project Gantt Chart for Generic Drug Development

    4.4. Generic Drug Development Project Phases (Execution Phase)

    5 Desk Research for Generic Drug Development

    5.1. Desk Research for Generic Drug Development

    5.2. European Medicines Agency (EMA)

    5.3. World Health Organization (WHO) & Food and Drug Administration (FDA)

    5.4. Pharmacopoeias & Dailymed

    5.5. Drugscom

    5.6. DrugBank

    5.7. Google Patents

    5.8. Espacenet

    6 Raw Material Selection for Generic Drug Development

    6.1. Raw Material Selection for Generic Drug Development

    6.2. Evaluation of Characteristics of API

    6.3. Evaluation of Stability Characteristics of API

    6.4. Evaluation of Suppliers of API

    6.5. Evaluation of Inactive Ingredient and Packaging Material

    7 Pre-Formulation Studies for Generic Drug Development

    7.1. Pre-Formulation Studies for Generic Drug Development

    7.2. Characterization of RLD

    7.3. Defining Quality Target Product Profile (QTPP)

    7.4. Evaluation of BE Requirements

    7.5. Evaluation of Inactive Ingredient Required for Formula

    7.6. Compatibility Study

    7.7. Supplying New material / Apparatus / Equipment

    7.8. Performing Pre-Formulation Trials

    8 Analytical Method Development Studies for Generic Drug Development

    8.1. Analytical Method Development Studies for Generic Drug Development-1

    8.2. Analytical Method Development Studies for Generic Drug Development-2

    8.3. Literature Search for Analytical Method Development

    8.4. Supplying Chemicals / Materials / Equipments

    8.5. Performing Method Development Studies

    8.6. Determining Acceptance Criteria

    8.7. Determining Dissolution Parameters

    8.8. Performing Stress Studies

    8.9. Performing Pre-Validation Studies

    9 Formulation Studies for Generic Drug Development

    9.1. Formulation Studies for Generic Drug Development

    9.2. Performing Formulation Trials

    9.3. Optimizing Formulation by using QBD

    9.4. Supplying Chemicals / Raw-Materials / Equipments for Pilot Manufacturing

    9.5. Preparing Formulations for Critical Material Attributes (CMA)

    9.6. Preparing Formulations for Critical Quality Attribute (CQA)

    9.7. Preparing Formulations for Critical Process Parameter (CPP)

    9.8. Discriminitive Dissolution Parameters

    9.9. Compatibility Study with Final Formula / Components

    10 Analytical Studies for Generic Drug Development

    10.1. Validation of Analytical Methods

    10.2. Evaluation Bulk and Product Characteristic / Performance

    10.3. Comparision Test Product with RLD In-vitro Conditions

    10.4. Performing Analysis of Formulations for Critical Material Attributes (CMA)

    10.5. Performing Analysis of Formulations for Critical Quality Attribute (CQA)

    10.6. Performing Analysis of Formulations for Critical Process Parameter (CPP)

    10.7. Performing Analysis of Formulations for for Discrimitive Dissolution Parameters

    10.8. Performing Analysis of Formulations for Compatibility Study with Final Formula / Components

    11 Pilot Manufacturing for Generic Drug Development

    11.1. Evaluation of Chemicals / Raw-materials / Equipments used for Pilot Manufacturing

    11.2. Performing Risk Assesment for Pilot Manufacturing

    11.3. Performing Quality Procedures for Pilot Manufacturing

    11.4. Documentation for Pilot Manufacturing

    11.5. Manufacturing of Pilot Batches

    12 Analysis of Pilot Batches for Generic Drug Development

    12.1. Analysis of Chemicals / Raw-Materials used for Pilot Manufacturing

    12.2. Analysis of Pilot Batches

    12.3. Comparision Pilot Batches with RLD in In-vitro Conditions

    12.4. Determining of BE Batches

    13 Performing Bioequivalency Study for Generic Drug Development

    13.1. Preparing Documentation for In-vitro Test Results

    13.2. Preparation of Samples for BE Studies

    13.3. Performing BE Studies

    13.4. Documentating of BE Results

    14 Preparation Registration Dossier for Generic Drug Development

    14.1. Preparation of Registration Dossier

    14.2. Performing of Registration Application

    15 Conclusion

    Who this course is for:

    • Learners who desire to take a part in Pharmaceutical Industry
    • Existing pharma professionals who are looking to progress in their jobs
    • Anyone who is looking to get entry in pharmaceutical industry

    User Reviews
    Rating
    0
    0
    0
    0
    0
    average 0
    Total votes0
    Focused display
    She is Aydan OZDEN. She is working as R&D Formulation Development Scientist at Pharmaceutical Company. She hold a Bachelor of Chemistry and a Master’s degree in Organic Chemistry. She offer proficiency in pharmaceutical Quality and Research and Development including but not limited to drug formulation development, drug manufacturing process, and associated scientific and regulatory elements. She has an extensive knowledge in pharmaceutical R&D, specially in the drug formulation development, drug manufacturing process and associated scientific and regulatory elements with 9 years experience. She also gained strong theoretical and practical background in conducting preformulation studies, formulation development, process optimization and scale up of generic drug products while knowing and applying main principles of medicinal chemistry.She has five Udemy courses presented below.- Quality in Pharmaceutical Industry (GMP & GLP & GHP): This course is strongly recommended for learners who interest pharmaceutical industry and desire to take a part in Quality,  Production, Technology Transfer and Research&Development Departments.- Pharmaceutical Dosage Forms & Basics of Pharma Industry: This course is strongly recommended for learners who interest pharmaceutical industry, especially for fresh graduate, and desire to take a part in Quality,  Production, Technology Transfer, Research & Development Departments and Business Development.- Pharmaceutical Manufacturing & Technology (GRANULATION):  This course is strongly recommended for learners who interest pharmaceutical drug manufacturing and desire to take a part in Quality Assurance,  Production, Technology Transfer and Research & Development Departments.- Pharmaceutical Manufacturing & Technology (COATING): This course is strongly recommended for learners who interest pharmaceutical drug manufacturing and desire to take a part in Quality Assurance,  Production, Technology Transfer and Research & Development Departments.- Preformulation Studies for Pharmaceutical Industry: This course is strongly recommended for learners who interest physicochemical properties of drug product and desire to take a part in Research & Development Department.- Preparation of Pharmaceutical Development Part for CTD: This course is strongly recommended for learners who interest pharmaceutical development / drug development and desire to take a part in Research & Development, Technology Transfer  and Regulatory Affairs Departments.
    Students take courses primarily to improve job-related skills.Some courses generate credit toward technical certification. Udemy has made a special effort to attract corporate trainers seeking to create coursework for employees of their company.
    • language english
    • Training sessions 64
    • duration 5:37:05
    • Release Date 2023/12/16